Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
success tags : Vaccine save search
Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD
Published: 2024-02-20 (Crawled : 12:30) - globenewswire.com
EVAX | News | $4.1 1.49% 1.46% 30K
|
Manufacturing
|
| O: 9.14%
H: 1.81%
C: -9.73%
vaccine ongoing collaboration
Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published
Published: 2024-02-15 (Crawled : 13:00) - globenewswire.com
VAXX | $0.418 -4.96% -5.22% 310K
|
|
| O: -1.25%
H: 0.0%
C: -9.96%
candidate vaccine cholesterol preclinical
Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
Published: 2023-11-29 (Crawled : 13:30) - globenewswire.com
DYAI A | $1.69 -6.11% -6.51% 17K
|
Health Technology
|
| O: -0.85%
H: 5.71%
C: -2.29%
candidate vaccine trial results
Global mRNA Vaccine Market Research Report 2023-2028: COVID-19 Success Opens New Avenues with with 444 Ongoing Clinical Studies Worldwide
Published: 2023-11-08 (Crawled : 03:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.91%
H: 0.0%
C: 0.0%
VERV | $6.74 -5.6% -5.93% 1.1M
|
Professional, Scientific, and T...
|
| O: 0.37%
H: 0.64%
C: -10.76%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: 0.46%
H: 0.46%
C: -0.23%
MRNA | News S | $103.45 -0.33% -0.33% 2M
|
Health Technology
|
| O: -0.01%
H: 0.03%
C: -3.14%
CVAC | $2.57 -3.57% -3.7% 920K
|
Health Technology
|
| O: 0.91%
H: 1.08%
C: -1.44%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.13%
H: 0.08%
C: -2.81%
ARCT 4 | $27.68 -8.13% -8.85% 620K
|
Health Technology
|
| O: -0.36%
H: 0.79%
C: -0.61%
covid-19 success report vaccine mrna worldwide ongoing research global market
Keys to Success in Vaccine Development for Special Populations
Published: 2023-05-11 (Crawled : 16:00) - ppdi.com
PPRUF | News | $359.318 37.56% 490
|
Consumer Non-Durables
|
| O: 1.76%
H: 1.01%
C: -0.94%
PPRUY | News | $36.19 -0.11% 360K
|
Manufacturing
|
| O: -1.04%
H: 1.12%
C: 1.12%
TMO | News | $547.25 -1.32% -0.02% 1.6M
|
Health Technology
|
| O: -0.26%
H: 0.69%
C: -0.43%
success vaccine
Press Release: Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine
Published: 2022-06-24 (Crawled : 06:00) - globenewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 8.01%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 3.49%
H: 0.0%
C: 0.0%
covid-19 report vaccine
Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine
Published: 2022-06-23 (Crawled : 12:00) - prnewswire.com
SNGX | $0.4963 5.15% -7.27% 4.2M
|
Health Technology
|
| O: 3.58%
H: 3.23%
C: -2.9%
vaccine
Emergex Vaccines Announces the Successful Coating of its Novel CD8+ T cell Adaptive COVID-19 Vaccine onto Zosano Pharma’s Micro-Needle Patch
Published: 2022-05-17 (Crawled : 18:00) - biospace.com/
ZSAN | $0.5576 7.23% -5.85%
|
Health Technology
|
| O: 2.72%
H: 7.32%
C: 6.88%
covid-19 vaccine
Moderna Announces its COVID-19 Vaccine Phase 2/3 Study in Children 6 Months to Under 6 Years Has Successfully Met Its Primary Endpoint
Published: 2022-03-23 (Crawled : 12:30) - biospace.com/
MRNA | News S | $103.45 -0.33% -0.33% 2M
|
Health Technology
|
| O: -1.1%
H: 0.59%
C: -3.21%
covid-19 children vaccine phase 2
Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine
Published: 2021-12-02 (Crawled : 13:00) - biospace.com/
SNGX | $0.4963 5.15% -7.27% 4.2M
|
Health Technology
|
| O: -4.6%
H: 1.22%
C: -6.0%
vaccine
Zosano Pharma Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch System
Published: 2021-11-17 (Crawled : 15:00) - biospace.com/
ZSAN | $0.5576 7.23% -5.85%
|
Health Technology
|
| O: 35.65%
H: 0.68%
C: -18.77%
covid vaccine
Mandates, boosters and pediatric vaccines: How to successfully manage the next phase of COVID-19 vaccination
Published: 2021-10-18 (Crawled : 17:00) - phreesia.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -1.8%
H: 1.87%
C: -0.28%
covid vaccine covid-19
Defence Therapeutics Successfully Engineered and Tested a Novel Intranasal COVID-19 Vaccine Formulation in Animals
Published: 2021-09-20 (Crawled : 15:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -3.65%
H: 0.0%
C: 0.0%
covid animals test vaccine defense covid-19
J&J on Pace for Another Vaccine Success, this Time for Ebola
Published: 2021-09-14 (Crawled : 14:15) - biospace.com/
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 0.36%
H: 0.08%
C: -0.96%
vaccine
Soligenix Announces Publication Demonstrating Successful Formulation and Heat Stabilization of Filovirus Vaccine Platform for Ebola and Marburg Virus Diseases
Published: 2021-08-23 (Crawled : 12:00) - biospace.com/
SNGX | $0.4963 5.15% -7.27% 4.2M
|
Health Technology
|
| O: 7.22%
H: 1.4%
C: 0.49%
disease vaccine marburg
iBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate
Published: 2021-07-15 (Crawled : 22:00) - globenewswire.com
IBIO | $1.89 -3.08% 0.0% 270K
|
Health Technology
|
| O: 3.05%
H: 3.7%
C: -2.22%
covid leo vaccine preclinical covid-19 pre-clinical
Longeveron Announces Successful Completion of Phase I/II Clinical Study of Lomecel-B Infusion in Aging Frailty Subjects to Improve Immune Response Following Influenza Vaccination
Published: 2021-04-15 (Crawled : 13:00) - globenewswire.com
LGVN | News P 6 d | $2.08 -41.08% -69.71% 3.3M
|
|
| O: -2.0%
H: 3.54%
C: -2.72%
influenza response vaccine lomecel-b
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.